Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-312023-03-31Fire service activitiestruefalsetrue2022-04-011The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 14277100 2022-03-31 14277100 2022-04-01 2023-03-31 14277100 2021-04-01 2022-03-31 14277100 2023-03-31 14277100 c:Director1 2022-04-01 2023-03-31 14277100 d:CurrentFinancialInstruments 2023-03-31 14277100 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 14277100 d:ShareCapital 2023-03-31 14277100 d:RetainedEarningsAccumulatedLosses 2023-03-31 14277100 c:OrdinaryShareClass1 2022-04-01 2023-03-31 14277100 c:OrdinaryShareClass1 2023-03-31 14277100 c:OrdinaryShareClass2 2022-04-01 2023-03-31 14277100 c:OrdinaryShareClass2 2023-03-31 14277100 c:FRS102 2022-04-01 2023-03-31 14277100 c:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 14277100 c:FullAccounts 2022-04-01 2023-03-31 14277100 c:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14277100










XILANT-XO LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MARCH 2023

 
XILANT-XO LIMITED
REGISTERED NUMBER: 14277100

BALANCE SHEET
AS AT 31 MARCH 2023

2023
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
100

Cash at bank and in hand
 5 
187

  
287

Creditors: amounts falling due within one year
 6 
(1,559)

Net current (liabilities)/assets
  
 
 
(1,272)

Total assets less current liabilities
  
(1,272)

  

Net (liabilities)/assets
  
(1,272)


Capital and reserves
  

Called up share capital 
 7 
100

Profit and loss account
  
(1,372)

  
(1,272)


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Paul Hawkins
Director

Date: 11 April 2024

The notes on pages 2 to 4 form part of these financial statements.
Page 1

 
XILANT-XO LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023

1.


General information

Xilant-XO Limited is a private company, limited by shares, incorporated and registered in England and Wales. The Company’s registered office is 6th Floor, 2 London Wall Place, London, EC2Y 5AU. The Company was incorporated on 4 August 2022 and began trading in February 2023.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The Company's functional and presentational currency is pounds sterling rounded to the nearest £1.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on a going concern basis as the shareholders have indicated the willingness and ability to support the Company for at least 12 months from the date of the approval of the financial statements, in order for the Company to meet liabilities they fall due.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 2

 
XILANT-XO LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.


3.


Employees

The average monthly number of employees, including directors, during the period was 1.


4.


Debtors

2023
£


Other debtors
100


Page 3

 
XILANT-XO LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023

5.


Cash and cash equivalents

2023
£

Cash at bank and in hand
187



6.


Creditors: Amounts falling due within one year

2023
£

Trade creditors
35

Other taxation and social security
24

Accruals and deferred income
1,500

1,559



7.


Share capital

2023
£
Allotted, called up and partly paid


50 A shares of £1.00 each
50
50 B shares of £1.00 each
50

100

On incorporation, the Company issued 100 Ordinary shares at par value of £1 per share. 


 
Page 4